BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

797 related articles for article (PubMed ID: 31948487)

  • 1. Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.
    Bart GB; Saxon A; Fiellin DA; McNeely J; Muench JP; Shanahan CW; Huntley K; Gore-Langton RE
    Addict Sci Clin Pract; 2020 Jan; 15(1):4. PubMed ID: 31948487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.
    Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J
    Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
    Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H
    Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Cascade of Care for responding to the opioid epidemic.
    Williams AR; Nunes EV; Bisaga A; Levin FR; Olfson M
    Am J Drug Alcohol Abuse; 2019; 45(1):1-10. PubMed ID: 30675818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder.
    Rossom RC; Sperl-Hillen JM; O'Connor PJ; Crain AL; Nightingale L; Pylkas A; Huntley KV; Bart G
    Addict Sci Clin Pract; 2021 Jun; 16(1):37. PubMed ID: 34130758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
    Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial.
    Hser YI; Ober AJ; Dopp AR; Lin C; Osterhage KP; Clingan SE; Mooney LJ; Curtis ME; Marsch LA; McLeman B; Hichborn E; Lester LS; Baldwin LM; Liu Y; Jacobs P; Saxon AJ
    Addict Sci Clin Pract; 2021 Apr; 16(1):24. PubMed ID: 33879260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.
    Cloutier RM; Cole ES; McDonough BL; Lomauro DA; Miller JP; Talbert AL; Bear TM; Bridges NC; Foulds AL; Taber R; Gordon AJ; Cochran GT; Kmiec J; Donohue JM; Kelley D; DiDomenico E; Adair D; Pringle JL
    Implement Res Pract; 2023; 4():26334895231152808. PubMed ID: 37091535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.
    Reif S; Brolin MF; Stewart MT; Fuchs TJ; Speaker E; Mazel SB
    J Subst Abuse Treat; 2020 Jan; 108():33-39. PubMed ID: 31358328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining a recovery-oriented cascade of care for opioid use disorder: A community-driven, statewide cross-sectional assessment.
    Yedinak JL; Goedel WC; Paull K; Lebeau R; Krieger MS; Thompson C; Buchanan AL; Coderre T; Boss R; Rich JD; Marshall BDL
    PLoS Med; 2019 Nov; 16(11):e1002963. PubMed ID: 31743335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care.
    Dela Cruz AM; Walker R; Pipes R; Wakhlu S; Trivedi MH
    Addict Sci Clin Pract; 2021 Feb; 16(1):12. PubMed ID: 33608060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
    Cochran G; Bruneau J; Cox N; Gordon AJ
    Subst Abus; 2020; 41(3):269-274. PubMed ID: 32697171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus.
    Rush AJ; Gore-Langton RE; Bart G; Bradley KA; Campbell CI; McKay J; Oslin DW; Saxon AJ; Winhusen TJ; Wu LT; Moran LM; Tai B
    Addict Sci Clin Pract; 2024 Feb; 19(1):14. PubMed ID: 38419116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of an electronic health records-based opioid use disorder algorithm by expert clinical adjudication among patients with prescribed opioids.
    Ranapurwala SI; Alam IZ; Pence BW; Carey TS; Christensen S; Clark M; Chelminski PR; Wu LT; Greenblatt LH; Korte JE; Wolfson M; Douglas HE; Bowlby LA; Capata M; Marshall SW
    Pharmacoepidemiol Drug Saf; 2023 May; 32(5):577-585. PubMed ID: 36585827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy.
    Jarrett JB; Bratberg J; Burns AL; Cochran G; DiPaula BA; Legreid Dopp A; Elmes A; Green TC; Hill LG; Homsted F; Hsia SL; Matthews ML; Ghitza UE; Wu LT; Bart G
    Subst Abus; 2023 Oct; 44(4):264-276. PubMed ID: 37902032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care.
    Rossom RC; Crain AL; O'Connor PJ; Wright E; Haller IV; Hooker SA; Sperl-Hillen JM; Olson A; Romagnoli K; Solberg L; Dehmer SP; Haapala J; Borgert-Spaniol C; Tusing L; Muegge J; Allen C; Ekstrom H; Huntley K; McCormack J; Bart G
    Contemp Clin Trials; 2023 Jan; 124():107012. PubMed ID: 36402275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System.
    Hawkins EJ; Malte CA; Gordon AJ; Williams EC; Hagedorn HJ; Drexler K; Blanchard BE; Burden JL; Knoeppel J; Danner AN; Lott A; Liberto JG; Saxon AJ
    JAMA Netw Open; 2021 Dec; 4(12):e2137238. PubMed ID: 34870679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment utilization among persons with opioid use disorder in the United States.
    Wu LT; Zhu H; Swartz MS
    Drug Alcohol Depend; 2016 Dec; 169():117-127. PubMed ID: 27810654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing Access to Medications for Opioid Use Disorder and Complementary and Integrative Health Services in Primary Care.
    Chang ET; Oberman RS; Cohen AN; Taylor SL; Gumm E; Mardian AS; Toy S; Revote A; Lewkowitz B; Yano EM
    J Gen Intern Med; 2020 Dec; 35(Suppl 3):918-926. PubMed ID: 33145686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinician Perceptions About a Decision Support System to Identify and Manage Opioid Use Disorder.
    Solberg LI; Hooker SA; Rossom RC; Bergdall A; Crabtree BF
    J Am Board Fam Med; 2021; 34(6):1096-1102. PubMed ID: 34772765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.